PICOSALAX - Medsafe
- 1 - PICOSALAX - PICOSAL004 12 January2015 PICOSALAX Sodium picosulfate 10.0mg, magnesium oxide 3.5g, citric acid 12.0g Presentation White crystalline powder.
Download PICOSALAX - Medsafe
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
Fluid and Electrolyte Disturbances Associated with …
samples.jbpub.comChapter 12 Fluid and Electrolyte Disturbances Associated with Tube Feedings Clinicians generally agree with the philosophy that “When the gut works, use it.”
Fluid and Electrolyte Management - Jones & …
samples.jbpub.com1 Chapter 7 Fluid and Electrolyte Management Billie Bartel and Elizabeth Gau Le a r n i n g Objectives 1. Identify and understand basic fluid and electrolyte abnormalities in
In AVIVA Plastic Container - Baxter
www.baxter.caPage 1 of 8 . PRESCRIBING INFORMATION . 5% Dextrose Injection, USP . In AVIVA Plastic Container . IV Fluid and Nutrient Replenisher . Baxter Corporation
GLUCOSE AND SODIUM CHLORIDE - medsafe.govt.nz
www.medsafe.govt.nzGLUCOSE AND SODIUM CHLORIDE New Zealand Data Sheet GLUCOSE & SODIUM CHLORIDE NZ Data Sheet 26 October 2015 Page 2 of 15 Baxter PHARMACOLOGY
NuLytely 181 Web Label
www.nulytely.comFULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE NuLYTELY is indicated for bowel cleansing prior to colonoscopy in adults and pediatric patients aged
Support Line December 2005 Volume 27 No. 6 Fluid …
www.nutritioncare.org– 13 – Abstract An understanding of basic fluid and electrolyte physiology can aid clinicians in administering parenteral nutrition (PN). Disturbances in electrolytes, fluid,